{"protocolSection": {"identificationModule": {"nctId": "NCT03900624", "orgStudyIdInfo": {"id": "IRB00187813"}, "organization": {"fullName": "Johns Hopkins All Children's Hospital", "class": "OTHER"}, "briefTitle": "Ideal Steroids for Asthma Treatment in the PICU", "officialTitle": "Ideal Steroids for Asthma Treatment in the PICU (iSTAT PICU): A Prospective, Comparative, Single-arm Study Assessing Dexamethasone Versus Methylprednisolone in Severe Status Asthmaticus Admitted to the Pediatric Intensive Care Unit", "acronym": "iSTAT PICU"}, "statusModule": {"statusVerifiedDate": "2024-02", "overallStatus": "COMPLETED", "expandedAccessInfo": {"hasExpandedAccess": false}, "startDateStruct": {"date": "2019-04-21", "type": "ACTUAL"}, "primaryCompletionDateStruct": {"date": "2021-12-31", "type": "ACTUAL"}, "completionDateStruct": {"date": "2022-05-15", "type": "ACTUAL"}, "studyFirstSubmitDate": "2019-04-01", "studyFirstSubmitQcDate": "2019-04-01", "studyFirstPostDateStruct": {"date": "2019-04-03", "type": "ACTUAL"}, "resultsFirstSubmitDate": "2022-08-04", "resultsFirstSubmitQcDate": "2022-08-04", "resultsFirstPostDateStruct": {"date": "2022-08-26", "type": "ACTUAL"}, "lastUpdateSubmitDate": "2024-02-19", "lastUpdatePostDateStruct": {"date": "2024-02-23", "type": "ACTUAL"}}, "sponsorCollaboratorsModule": {"responsibleParty": {"type": "SPONSOR"}, "leadSponsor": {"name": "Johns Hopkins All Children's Hospital", "class": "OTHER"}}, "oversightModule": {"oversightHasDmc": false, "isFdaRegulatedDrug": true, "isFdaRegulatedDevice": false, "isUsExport": false}, "descriptionModule": {"briefSummary": "Determine if differences in (1) pediatric intensive care unit length of stay, (2) continuous nebulized albuterol duration, and (3) a composite outcome of advanced asthma therapy incidence including use of non-invasive ventilation (NIV), terbutaline, inhaled helium and mechanical ventilation between cohorts of children admitted with status asthmaticus to the PICU treated with either IV dexamethasone (DM) or methylprednisolone (MP).", "detailedDescription": "As the pathophysiology of an acute asthma exacerbation is dysregulated inflammatory pathways, standard treatment includes the prompt initiation of intravenous systemic corticosteroids. Corticosteroids reduce the production of many mediators involved in the inflammatory process and inhibit macrophages, monocytes, T-lymphocytes, eosinophils, and basophils, which are activated during this process. Furthermore, corticosteroids improve the efficacy of beta-2 agonists, such as albuterol, a nebulized medication used for bronchodilation in acute asthma exacerbations. There remains an ongoing dialogue among the expert medical community regarding the superiority of specific IV corticosteroid, dosing, route and delivery. This debate continues secondary to a lack of definitive comparative data in the literature. While the benefits of receiving systemic corticosteroids has been demonstrated in multiple studies, to date, no head-to-head trials have been conducted comparing IV systemic corticosteroids in the PICU setting (DM vs. MP).\n\nWhile several systemic corticosteroids are FDA approved for the treatment of asthma exacerbation including prednisone, prednisolone, MP and DM, the standard practice in PICU-level care is IV MP every 6 hours until enteral medications can be safely tolerated. Recent data from emergency room literature would suggest there is equipoise in use of dexamethasone as an alternative for methylprednisolone due to its increased glucocorticoid (anti-inflammatory) potency. Steroid agents are chosen at the discretion of clinical providers based upon a child's capacity to tolerate enteral medications and the specific clinical setting (outpatient vs. general inpatient vs. critical inpatient).\n\nThe investigators have performed a retrospective study over a 2-year period to assess if differences in clinical outcomes or adverse events exist in cohorts defined by DM exposure in the ER. Their data revealed no differences, but most children were switched to MP during their PICU stay making data analyses severely confounded by exposure to the defining characteristics of the comparative cohort. The investigators seek to first prospectively consent individuals to receive DM during their PICU asthma treatment and compare outcomes to PICU asthmatics concurrently admitted to the PICU receiving local standard care (MP). Johns Hopkins All Children's Hospital (JHACH) admits approximately 150 asthmatics per year in the PICU and the investigators hope to enroll up to 50 subjects into a DM only arm. The comparative standard care arm will be assessed at the end of the study period. Primary outcomes include (1) PICU Length of Stay, (2) Continuous nebulized albuterol duration, and (3) a composite outcome including use of non-invasive ventilation (NIV), terbutaline, inhaled helium, inhaled anesthetic gas, mechanical ventilation, and extracorporeal life support. This research will provide the needed epidemiologic and basic comparative data required to power and conduct a definitive, head-to-head trial of DM vs. MP."}, "conditionsModule": {"conditions": ["Asthma Childhood"]}, "designModule": {"studyType": "INTERVENTIONAL", "phases": ["PHASE4"], "designInfo": {"allocation": "NON_RANDOMIZED", "interventionModel": "PARALLEL", "interventionModelDescription": "Single Arm Treatment Group with a Prospective, Comparative Cohort Receiving Standard Care", "primaryPurpose": "TREATMENT", "maskingInfo": {"masking": "NONE"}}, "enrollmentInfo": {"count": 92, "type": "ACTUAL"}}, "armsInterventionsModule": {"armGroups": [{"label": "Methylprednisolone Arm", "type": "NO_INTERVENTION", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone."}, {"label": "Dexamethasone Arm", "type": "EXPERIMENTAL", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus.", "interventionNames": ["Drug: Dexamethasone"]}], "interventions": [{"type": "DRUG", "name": "Dexamethasone", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus", "armGroupLabels": ["Dexamethasone Arm"]}]}, "outcomesModule": {"primaryOutcomes": [{"measure": "Length of Stay", "description": "Hospital length of stay measured in days.", "timeFrame": "From enrollment through hospital discharge, up to 1 week"}], "secondaryOutcomes": [{"measure": "Duration of Continuous Nebulized Albuterol", "description": "Duration (in days) of continuous nebulized albuterol.", "timeFrame": "From enrollment through hospital discharge, up to 1 week"}], "otherOutcomes": [{"measure": "Number of Participants Receiving an Adjunctive Asthma Therapy", "description": "Number of participants receiving an adjunctive therapy:\n\n* use of non-invasive ventilation (NIV)\n* terbutaline\n* inhaled helium\n* inhaled anesthetic gas\n* mechanical ventilation\n* extracorporeal life support", "timeFrame": "From enrollment through hospital discharge, up to 1 week"}, {"measure": "Corticosteroid-related Adverse Events", "description": "Rates of known corticosteroid-related adverse events including clinically-relevant gastrointestinal bleeding, gastritis, ventilator associated pneumonia, necrotizing enterocolitis, hypertension, hyperglycemia, altered mentation (including hallucinations and delirium), and adrenal insufficiency observed prior to hospital discharge.", "timeFrame": "From enrollment through hospital discharge, up to 1 week"}]}, "eligibilityModule": {"eligibilityCriteria": "Inclusion Criteria:\n\n* Inclusion criteria are children 5 to 17 years of age with primary admission diagnoses of acute asthma exacerbation or status asthmaticus admitted to the PICU\n\nExclusion Criteria:\n\n* children with existing tracheostomy, cystic fibrosis, and pulmonary hypertension", "healthyVolunteers": false, "sex": "ALL", "minimumAge": "5 Years", "maximumAge": "17 Years", "stdAges": ["CHILD"]}, "contactsLocationsModule": {"overallOfficials": [{"name": "Anthony A Sochet, MD, MS", "affiliation": "Johns Hopkins All Children's Hospital", "role": "PRINCIPAL_INVESTIGATOR"}], "locations": [{"facility": "Johns Hopkins All Children's Hospital", "city": "Saint Petersburg", "state": "Florida", "zip": "33701", "country": "United States", "geoPoint": {"lat": 27.77086, "lon": -82.67927}}]}, "referencesModule": {"references": [{"pmid": "9728226", "type": "BACKGROUND", "citation": "Taylor IK, Shaw RJ. The mechanism of action of corticosteroids in asthma. Respir Med. 1993 May;87(4):261-77. doi: 10.1016/0954-6111(93)90022-r. No abstract available."}, {"pmid": "1968733", "type": "BACKGROUND", "citation": "Svedmyr N. Action of corticosteroids on beta-adrenergic receptors. Clinical aspects. Am Rev Respir Dis. 1990 Feb;141(2 Pt 2):S31-8."}, {"pmid": "8414819", "type": "BACKGROUND", "citation": "Scarfone RJ, Fuchs SM, Nager AL, Shane SA. Controlled trial of oral prednisone in the emergency department treatment of children with acute asthma. Pediatrics. 1993 Oct;92(4):513-8."}, {"pmid": "8135557", "type": "BACKGROUND", "citation": "Connett GJ, Warde C, Wooler E, Lenney W. Prednisolone and salbutamol in the hospital treatment of acute asthma. Arch Dis Child. 1994 Mar;70(3):170-3. doi: 10.1136/adc.70.3.170."}, {"pmid": "2882288", "type": "BACKGROUND", "citation": "Storr J, Barrell E, Barry W, Lenney W, Hatcher G. Effect of a single oral dose of prednisolone in acute childhood asthma. Lancet. 1987 Apr 18;1(8538):879-82. doi: 10.1016/s0140-6736(87)92857-1."}, {"pmid": "2267922", "type": "BACKGROUND", "citation": "Gleeson JG, Loftus BG, Price JF. Placebo controlled trial of systemic corticosteroids in acute childhood asthma. Acta Paediatr Scand. 1990 Nov;79(11):1052-8. doi: 10.1111/j.1651-2227.1990.tb11382.x."}, {"pmid": "7359263", "type": "BACKGROUND", "citation": "Kattan M, Gurwitz D, Levison H. Corticosteroids in status asthmaticus. J Pediatr. 1980 Mar;96(3 Pt 2):596-9. doi: 10.1016/s0022-3476(80)80872-9."}, {"pmid": "24515516", "type": "BACKGROUND", "citation": "Keeney GE, Gray MP, Morrison AK, Levas MN, Kessler EA, Hill GD, Gorelick MH, Jackson JL. Dexamethasone for acute asthma exacerbations in children: a meta-analysis. Pediatrics. 2014 Mar;133(3):493-9. doi: 10.1542/peds.2013-2273. Epub 2014 Feb 10."}, {"pmid": "29173304", "type": "BACKGROUND", "citation": "Paniagua N, Lopez R, Munoz N, Tames M, Mojica E, Arana-Arri E, Mintegi S, Benito J. Randomized Trial of Dexamethasone Versus Prednisone for Children with Acute Asthma Exacerbations. J Pediatr. 2017 Dec;191:190-196.e1. doi: 10.1016/j.jpeds.2017.08.030."}]}, "ipdSharingStatementModule": {"ipdSharing": "NO"}}, "resultsSection": {"participantFlowModule": {"groups": [{"id": "FG000", "title": "Methylprednisolone Arm - Standard Care", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone 0.5mg/kg/dose every 6-hours for 5-days."}, {"id": "FG001", "title": "Dexamethasone Arm - Interventional Arm", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone 0.25 mg/kg/dose every 6 hours for 2-days for children admitted to the PICU with status asthmaticus.\n\nDexamethasone: Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus"}], "periods": [{"title": "Overall Study", "milestones": [{"type": "STARTED", "achievements": [{"groupId": "FG000", "numSubjects": "61"}, {"groupId": "FG001", "numSubjects": "31"}]}, {"type": "COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "61"}, {"groupId": "FG001", "numSubjects": "31"}]}, {"type": "NOT COMPLETED", "achievements": [{"groupId": "FG000", "numSubjects": "0"}, {"groupId": "FG001", "numSubjects": "0"}]}]}]}, "baselineCharacteristicsModule": {"groups": [{"id": "BG000", "title": "Methylprednisolone Arm - Standard Care", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone."}, {"id": "BG001", "title": "Dexamethasone Arm - Interventional Arm", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus.\n\nDexamethasone: Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus"}, {"id": "BG002", "title": "Total", "description": "Total of all reporting groups"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "61"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "92"}]}], "measures": [{"title": "Age, Continuous", "paramType": "MEAN", "dispersionType": "STANDARD_DEVIATION", "unitOfMeasure": "years", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "61"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "92"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "9.7", "spread": "3.8"}, {"groupId": "BG001", "value": "9.3", "spread": "3.5"}, {"groupId": "BG002", "value": "9.6", "spread": "3.8"}]}]}]}, {"title": "Sex: Female, Male", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "61"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "92"}]}], "categories": [{"title": "Female", "measurements": [{"groupId": "BG000", "value": "30"}, {"groupId": "BG001", "value": "13"}, {"groupId": "BG002", "value": "43"}]}, {"title": "Male", "measurements": [{"groupId": "BG000", "value": "31"}, {"groupId": "BG001", "value": "18"}, {"groupId": "BG002", "value": "49"}]}]}]}, {"title": "Race and Ethnicity Not Collected", "populationDescription": "Race and Ethnicity were not collected from any participant.", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "0"}, {"groupId": "BG001", "value": "0"}, {"groupId": "BG002", "value": "0"}]}], "categories": [{"measurements": [{"groupId": "BG002", "value": "0"}]}]}]}, {"title": "NHLBI Asthma Classification", "description": "National Heart Lung and Blood Institute Chronic Asthma Severity Classification", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "61"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "92"}]}], "categories": [{"title": "Intermittent", "measurements": [{"groupId": "BG000", "value": "10"}, {"groupId": "BG001", "value": "4"}, {"groupId": "BG002", "value": "14"}]}, {"title": "Mild Persistent", "measurements": [{"groupId": "BG000", "value": "13"}, {"groupId": "BG001", "value": "7"}, {"groupId": "BG002", "value": "20"}]}, {"title": "Moderate Persistent", "measurements": [{"groupId": "BG000", "value": "26"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "36"}]}, {"title": "Severe Persistent", "measurements": [{"groupId": "BG000", "value": "12"}, {"groupId": "BG001", "value": "10"}, {"groupId": "BG002", "value": "22"}]}]}]}, {"title": "Pediatric Asthma Severity Score", "description": "Score ranges from 5-15. Greater scores signify greater severity of illness with respect to asthma exacerbation.", "paramType": "MEDIAN", "dispersionType": "INTER_QUARTILE_RANGE", "unitOfMeasure": "units on a scale", "classes": [{"denoms": [{"units": "Participants", "counts": [{"groupId": "BG000", "value": "61"}, {"groupId": "BG001", "value": "31"}, {"groupId": "BG002", "value": "92"}]}], "categories": [{"measurements": [{"groupId": "BG000", "value": "11", "lowerLimit": "9", "upperLimit": "12"}, {"groupId": "BG001", "value": "10.5", "lowerLimit": "8", "upperLimit": "12"}, {"groupId": "BG002", "value": "11", "lowerLimit": "8", "upperLimit": "12"}]}]}]}]}, "outcomeMeasuresModule": {"outcomeMeasures": [{"type": "PRIMARY", "title": "Length of Stay", "description": "Hospital length of stay measured in days.", "reportingStatus": "POSTED", "paramType": "MEAN", "dispersionType": "Inter-Quartile Range", "unitOfMeasure": "days", "timeFrame": "From enrollment through hospital discharge, up to 1 week", "groups": [{"id": "OG000", "title": "Methylprednisolone Arm - Standard Care", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone."}, {"id": "OG001", "title": "Dexamethasone Arm - Interventional Arm", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus.\n\nDexamethasone: Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "61"}, {"groupId": "OG001", "value": "31"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "2.9", "lowerLimit": "2.1", "upperLimit": "4"}, {"groupId": "OG001", "value": "2.9", "lowerLimit": "1.8", "upperLimit": "4.1"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.632", "statisticalMethod": "Wilcoxon (Mann-Whitney)"}]}, {"type": "SECONDARY", "title": "Duration of Continuous Nebulized Albuterol", "description": "Duration (in days) of continuous nebulized albuterol.", "reportingStatus": "POSTED", "paramType": "MEDIAN", "dispersionType": "Inter-Quartile Range", "unitOfMeasure": "days", "timeFrame": "From enrollment through hospital discharge, up to 1 week", "groups": [{"id": "OG000", "title": "Methylprednisolone Arm - Standard Care", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone."}, {"id": "OG001", "title": "Dexamethasone Arm - Interventional Arm", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus.\n\nDexamethasone: Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "61"}, {"groupId": "OG001", "value": "31"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "1", "lowerLimit": "0.5", "upperLimit": "1.9"}, {"groupId": "OG001", "value": "0.8", "lowerLimit": "0.5", "upperLimit": "1.7"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.725", "statisticalMethod": "Wilcoxon (Mann-Whitney)"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Number of Participants Receiving an Adjunctive Asthma Therapy", "description": "Number of participants receiving an adjunctive therapy:\n\n* use of non-invasive ventilation (NIV)\n* terbutaline\n* inhaled helium\n* inhaled anesthetic gas\n* mechanical ventilation\n* extracorporeal life support", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "From enrollment through hospital discharge, up to 1 week", "groups": [{"id": "OG000", "title": "Methylprednisolone Arm - Standard Care", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone."}, {"id": "OG001", "title": "Dexamethasone Arm - Interventional Arm", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus.\n\nDexamethasone: Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "61"}, {"groupId": "OG001", "value": "31"}]}], "classes": [{"categories": [{"measurements": [{"groupId": "OG000", "value": "41"}, {"groupId": "OG001", "value": "16"}]}]}], "analyses": [{"groupIds": ["OG000", "OG001"], "nonInferiorityType": "SUPERIORITY", "pValue": "0.725", "statisticalMethod": "Wilcoxon (Mann-Whitney)"}]}, {"type": "OTHER_PRE_SPECIFIED", "title": "Corticosteroid-related Adverse Events", "description": "Rates of known corticosteroid-related adverse events including clinically-relevant gastrointestinal bleeding, gastritis, ventilator associated pneumonia, necrotizing enterocolitis, hypertension, hyperglycemia, altered mentation (including hallucinations and delirium), and adrenal insufficiency observed prior to hospital discharge.", "reportingStatus": "POSTED", "paramType": "COUNT_OF_PARTICIPANTS", "unitOfMeasure": "Participants", "timeFrame": "From enrollment through hospital discharge, up to 1 week", "groups": [{"id": "OG000", "title": "Methylprednisolone Arm", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone."}, {"id": "OG001", "title": "Dexamethasone Arm", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus.\n\nDexamethasone: Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus"}], "denoms": [{"units": "Participants", "counts": [{"groupId": "OG000", "value": "61"}, {"groupId": "OG001", "value": "31"}]}], "classes": [{"title": "Hyperglycemia", "categories": [{"measurements": [{"groupId": "OG000", "value": "7"}, {"groupId": "OG001", "value": "2"}]}]}, {"title": "Hypertension", "categories": [{"measurements": [{"groupId": "OG000", "value": "1"}, {"groupId": "OG001", "value": "1"}]}]}, {"title": "Adrenal insufficiency", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Altered mentation", "categories": [{"measurements": [{"groupId": "OG000", "value": "2"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Clinically-relevant gastrointestinal bleeding", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Gastritis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Necrotizing enterocolitis", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}, {"title": "Ventilator associated pneumonia", "categories": [{"measurements": [{"groupId": "OG000", "value": "0"}, {"groupId": "OG001", "value": "0"}]}]}]}]}, "adverseEventsModule": {"frequencyThreshold": "0", "timeFrame": "From enrollment to hospital discharge or 30-days; whichever comes first.", "eventGroups": [{"id": "EG000", "title": "Methylprednisolone Arm - Standard Care", "description": "Non-randomized, prospective, observational arm of children receiving standard care for status asthmaticus in the PICU with intravenous methylprednisolone.", "deathsNumAffected": 0, "deathsNumAtRisk": 61, "seriousNumAffected": 0, "seriousNumAtRisk": 61, "otherNumAffected": 12, "otherNumAtRisk": 61}, {"id": "EG001", "title": "Dexamethasone Arm - Interventional Arm", "description": "Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus.\n\nDexamethasone: Non-randomized, open-label, prospective use of intravenous dexamethasone for children admitted to the PICU with status asthmaticus", "deathsNumAffected": 0, "deathsNumAtRisk": 31, "seriousNumAffected": 0, "seriousNumAtRisk": 31, "otherNumAffected": 3, "otherNumAtRisk": 31}], "otherEvents": [{"term": "Hyperglycemia", "organSystem": "Endocrine disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "notes": "Steroid induced hyperglycemia", "stats": [{"groupId": "EG000", "numEvents": 7, "numAffected": 7, "numAtRisk": 61}, {"groupId": "EG001", "numEvents": 2, "numAffected": 2, "numAtRisk": 31}]}, {"term": "Hypertension", "organSystem": "General disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 1, "numAffected": 1, "numAtRisk": 61}, {"groupId": "EG001", "numEvents": 1, "numAffected": 1, "numAtRisk": 31}]}, {"term": "Adrenal Insufficiency", "organSystem": "Endocrine disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 61}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}]}, {"term": "Altered Mentation", "organSystem": "Nervous system disorders", "assessmentType": "NON_SYSTEMATIC_ASSESSMENT", "stats": [{"groupId": "EG000", "numEvents": 2, "numAffected": 2, "numAtRisk": 61}, {"groupId": "EG001", "numEvents": 0, "numAffected": 0, "numAtRisk": 31}]}]}, "moreInfoModule": {"certainAgreement": {"piSponsorEmployee": false, "restrictiveAgreement": false}, "pointOfContact": {"title": "Dr. Anthony Sochet", "organization": "Johns Hopkins All Children's Hospital", "email": "Anthony.Sochet@jhmi.edu", "phone": "7277672912"}}}, "documentSection": {"largeDocumentModule": {"largeDocs": [{"typeAbbrev": "Prot_SAP", "hasProtocol": true, "hasSap": true, "hasIcf": false, "label": "Study Protocol and Statistical Analysis Plan", "date": "2019-03-28", "uploadDate": "2022-05-15T03:13", "filename": "Prot_SAP_000.pdf", "size": 291519}]}}, "derivedSection": {"miscInfoModule": {"versionHolder": "2024-06-24"}, "conditionBrowseModule": {"meshes": [{"id": "D000001249", "term": "Asthma"}], "ancestors": [{"id": "D000001982", "term": "Bronchial Diseases"}, {"id": "D000012140", "term": "Respiratory Tract Diseases"}, {"id": "D000008173", "term": "Lung Diseases, Obstructive"}, {"id": "D000008171", "term": "Lung Diseases"}, {"id": "D000012130", "term": "Respiratory Hypersensitivity"}, {"id": "D000006969", "term": "Hypersensitivity, Immediate"}, {"id": "D000006967", "term": "Hypersensitivity"}, {"id": "D000007154", "term": "Immune System Diseases"}], "browseLeaves": [{"id": "M4556", "name": "Asthma", "asFound": "Asthma", "relevance": "HIGH"}, {"id": "M16017", "name": "Status Asthmaticus", "relevance": "LOW"}, {"id": "M5258", "name": "Bronchial Diseases", "relevance": "LOW"}, {"id": "M14977", "name": "Respiratory Tract Diseases", "relevance": "LOW"}, {"id": "M11168", "name": "Lung Diseases", "relevance": "LOW"}, {"id": "M11170", "name": "Lung Diseases, Obstructive", "relevance": "LOW"}, {"id": "M10018", "name": "Hypersensitivity", "relevance": "LOW"}, {"id": "M14967", "name": "Respiratory Hypersensitivity", "relevance": "LOW"}, {"id": "M10020", "name": "Hypersensitivity, Immediate", "relevance": "LOW"}, {"id": "M10200", "name": "Immune System Diseases", "relevance": "LOW"}], "browseBranches": [{"abbrev": "BC08", "name": "Respiratory Tract (Lung and Bronchial) Diseases"}, {"abbrev": "BC20", "name": "Immune System Diseases"}, {"abbrev": "All", "name": "All Conditions"}]}, "interventionBrowseModule": {"meshes": [{"id": "D000003907", "term": "Dexamethasone"}], "ancestors": [{"id": "D000000893", "term": "Anti-Inflammatory Agents"}, {"id": "D000000932", "term": "Antiemetics"}, {"id": "D000001337", "term": "Autonomic Agents"}, {"id": "D000018373", "term": "Peripheral Nervous System Agents"}, {"id": "D000045505", "term": "Physiological Effects of Drugs"}, {"id": "D000005765", "term": "Gastrointestinal Agents"}, {"id": "D000005938", "term": "Glucocorticoids"}, {"id": "D000006728", "term": "Hormones"}, {"id": "D000006730", "term": "Hormones, Hormone Substitutes, and Hormone Antagonists"}, {"id": "D000018931", "term": "Antineoplastic Agents, Hormonal"}, {"id": "D000000970", "term": "Antineoplastic Agents"}], "browseLeaves": [{"id": "M11749", "name": "Methylprednisolone", "relevance": "LOW"}, {"id": "M1833", "name": "Methylprednisolone Acetate", "relevance": "LOW"}, {"id": "M11750", "name": "Methylprednisolone Hemisuccinate", "relevance": "LOW"}, {"id": "M14120", "name": "Prednisolone", "relevance": "LOW"}, {"id": "M229449", "name": "Prednisolone acetate", "relevance": "LOW"}, {"id": "M211887", "name": "Prednisolone hemisuccinate", "relevance": "LOW"}, {"id": "M248881", "name": "Prednisolone phosphate", "relevance": "LOW"}, {"id": "M7102", "name": "Dexamethasone", "asFound": "Health", "relevance": "HIGH"}, {"id": "M235549", "name": "Dexamethasone acetate", "relevance": "LOW"}, {"id": "M4217", "name": "Anti-Inflammatory Agents", "relevance": "LOW"}, {"id": "M4251", "name": "Antiemetics", "relevance": "LOW"}, {"id": "M8881", "name": "Gastrointestinal Agents", "relevance": "LOW"}, {"id": "M9047", "name": "Glucocorticoids", "relevance": "LOW"}, {"id": "M9789", "name": "Hormones", "relevance": "LOW"}, {"id": "M9788", "name": "Hormone Antagonists", "relevance": "LOW"}, {"id": "M20966", "name": "Antineoplastic Agents, Hormonal", "relevance": "LOW"}], "browseBranches": [{"abbrev": "Infl", "name": "Anti-Inflammatory Agents"}, {"abbrev": "AnEm", "name": "Antiemetics"}, {"abbrev": "NeuroAg", "name": "Neuroprotective Agents"}, {"abbrev": "Gast", "name": "Gastrointestinal Agents"}, {"abbrev": "All", "name": "All Drugs and Chemicals"}, {"abbrev": "ANeo", "name": "Antineoplastic Agents"}]}}, "hasResults": true}